Brokerages Set The Cooper Companies, Inc. (NASDAQ:COO) Target Price at $117.00

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twelve analysts that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $117.00.

Several equities research analysts have recently weighed in on COO shares. Morgan Stanley lowered their target price on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Friday, December 6th. Citigroup dropped their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a report on Friday, December 6th. Finally, Wells Fargo & Company boosted their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th.

Cooper Companies Stock Performance

NASDAQ COO traded down $0.81 during midday trading on Thursday, hitting $91.88. The company had a trading volume of 1,107,737 shares, compared to its average volume of 1,041,607. The firm has a fifty day simple moving average of $98.15 and a two-hundred day simple moving average of $98.77. Cooper Companies has a fifty-two week low of $84.76 and a fifty-two week high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock has a market cap of $18.34 billion, a price-to-earnings ratio of 47.12, a P/E/G ratio of 2.40 and a beta of 0.97.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies's revenue for the quarter was up 9.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.87 EPS. Equities analysts forecast that Cooper Companies will post 3.98 earnings per share for the current fiscal year.

Institutional Trading of Cooper Companies

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Ashton Thomas Securities LLC acquired a new position in Cooper Companies during the third quarter valued at approximately $25,000. Covestor Ltd raised its stake in shares of Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company's stock worth $37,000 after purchasing an additional 200 shares in the last quarter. Brown Brothers Harriman & Co. boosted its holdings in shares of Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock valued at $46,000 after buying an additional 275 shares during the last quarter. Friedenthal Financial bought a new position in shares of Cooper Companies in the third quarter valued at $50,000. Finally, Cromwell Holdings LLC acquired a new position in Cooper Companies during the third quarter worth $52,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.